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Abstract. The Sri Lankan Anti-Filariasis campaign distributed ﬁve rounds of mass drug administration (MDA with
diethylcarbamazine plus albendazole) to some 10million people in eight districts between 2002 and 2006. Sri Lanka was
recognized by theWHO for having eliminated lymphatic ﬁlariasis (LF) as a public health problem in 2016. However, recent
studies by our group documented pockets with persistent LF in coastal Sri Lanka, especially in Galle district. The present
study was performed to reexamine an area previously identiﬁed as a potential hotspot for persistent LF (Balapitiya Public
Health Inspector area, population 17,500). A community survey documented high rates for circulating ﬁlarial antigenemia
(3%, conﬁdence interval [CI]: 1.8–4.9) and microﬁlaremia (1%, CI: 0.5–2.5%). Circulating ﬁlarial antigenemia rates were
2.8-fold higher in males than females. High prevalence was also observed for anti-ﬁlarial antibodies in young children
(5.7%, CI: 3.7–8.4%) and for ﬁlarial DNA in vector mosquitoes (5.2%, CI: 4.2–6.3%). Spatial data showed that persistent
LF was dispersed across the entire study area. Other studies showed that persistent LF was not limited to Balapitiya and
not solved by additional rounds of MDA. Molecular xenomonitoring studies conducted in 2016 in 22 of 168 Public Health
Midwife areas in the coastal Galle evaluation unit (approximate population 600,000) found that 179 of 660 (27%) pools of
Culex collected from all areas were positive forWuchereria bancrofti DNA by quantitative polymerase chain reaction; the
estimated infection rate inmosquitoes was 1.26%, CI: 1.0–1.5%. Interventions other than routineMDAwill be required to
remove LF hotspots in Balapitiya and in other areas in coastal Sri Lanka.
INTRODUCTION
Lymphatic ﬁlariasis (LF) has been endemic in Sri Lanka for
hundreds of years with the highest rates in the “ﬁlariasis belt”
in the western and southern parts of the country.1–3 The Anti-
Filariasis Campaign (AFC, established in 1947) implemented a
variety of control activities over many years that reduced in-
fection prevalence to low levels by 1999. After providingmass
drug administration (MDA) with diethylcarbamazine (DEC) for
three years starting in 1999, the AFC provided ﬁve annual
rounds of MDA with DEC plus albendazole in all eight en-
demic districts (implementation units, IU) between 2002 and
2006.4–6 The AFC conducted post-MDA surveillance activi-
ties according to theWHOguidelines, and all evaluation units
(EUs) in endemic districts easily passed transmission assess-
ment surveys (TAS) in 2013.7 These surveys are designed to
test whether ﬁlarial antigenemia prevalence in young school
children is less than 2% with 95% certainty.8 However, prior
studies by our group have shown that TAS was not sensitive
for detecting ongoing transmission of Wuchereria bancrofti
inmany areas in Sri Lanka,9 and this is likely to be true in other
areas where LF is transmitted by Culex mosquitoes. This
suggests that children aged 6–8 years may not be good
sentinels for detecting residual infections in this type of set-
ting but their antibody responses can be good markers for
recent transmission.
Basedon the encouragingTAS results andother criteria, the
WHO recognized that Sri Lanka had eliminated LF as a public
health problem in 2016 but recommended that the country
continue surveillance efforts and intervention to clear residual
infections in foci with persistent infections.10,11
Lymphatic ﬁlariasis is highly focal infection, and the epi-
demiological models suggest that the distribution of the in-
fection may become more heterogeneous following multiple
rounds of MDA.12,13 We performed comprehensive LF sur-
veys in 19 Public Health Inspector (PHI) areas that were
considered to be at risk for persistent infection in
2011–2013.9 The surveillance package included community
surveys for circulating ﬁlarial antigenemia (CFA) and micro-
ﬁlaremia (Mf), school surveys for CFA and anti-ﬁlarial anti-
bodies, and molecular xenomonitoring (MX, systematic
sampling and testing Culex quinquefasciatus for ﬁlarial DNA
by PCR).9 All 19 sentinel areas studied had evidence for
persistent LF, but some areas had stronger signals than
others. Based on results of that study, we suggested revised
endpoint targets (upper 95% conﬁdence intervals [CIs]) for
ﬁlariasis elimination programs in areas with Culex trans-
mission as follows: community CFA, < 2%; anti-ﬁlarial anti-
body prevalence in ﬁrst and second grade primary school
children, < 5%; prevalence of ﬁlarial DNA in Culex mosqui-
toes (fed, gravid, or semi-gravid, collected with gravid
traps), < 1%.9 Follow-up surveys conducted in six PHIs that
had strong signals in 2011–2013 (approximately 3 years after
the previous surveys) found that two PHIs in Galle district
and one in Matara district failed to meet these endpoint tar-
gets in 2015–2016.14 These results and a district-wide MX
study in the Galle district coastal EU (population ∼600,000)
suggested that there were many hotspots with persistent
infection and transmission in that EU despite the fact that it
had easily passed pre-TAS and TAS surveys that were con-
ducted according to the WHO guidelines in 2013.15 We now
report results of comprehensive surveys thatwere performed
in a suspected LF hotspot within the Galle coastal EU,
namely theBalapitiya PHI area. The study also reports results
from other post-MDA surveillance activities conducted in the
Galle coastal EU after 2015.
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METHODS
Study sites. The BalapitiyaMedical Ofﬁcer of Health (MOH)
area is located in southwestern Sri Lanka; it is bordered by the
Indian Ocean to the west and by Bentota and Ambalangoda
MOH areas that also had evidence of persistent LF in recent
surveys. The Balapitiya MOH area comprised ﬁve PHI areas,
and these comprised 22 Public Health Midwife (PHM) areas
with an average population of 3,500 (range 2,400–5,100).
Much of the present study was conducted in the Balapitiya
PHI area in theMOHarea of the same name. Five PHMareas
containing 11 Grama Niladhari divisions are within the
Balapitiya PHI area.
In an attempt to mop-up pockets with persistent ﬁlariasis in
Galle district, the AFC provided MDA with DEC plus alben-
dazole in 14 MOH areas in the district (including Balapitiya) in
September 2014 and in September 2015. The reported MDA
compliance rates for Galle district were 72%and 85% in 2014
and 2015, respectively. Compliance rates in the Balapitiya
MOH area for these years were 78% and 82% (AFC un-
published reports). This study reports results of a compre-
hensive LF survey in the Balapitiya PHI area that was
conducted between March and June in 2015, some 6months
after the round of MDA that was provided in 2014. Additional
MX surveys were also conducted between March and May in
2016 (6 months after the 2015 MDA) in eight of the 22 PHM
areas in the Balapitiya MOH area, and the areas surveyed
included some PHM areas that were also surveyed in 2015.
The 2016 MX surveys also sampled 14 additional PHM areas
in other MOH areas within the Galle coastal EU that had sig-
nals for persistent LF in prior surveys.
Assessment of LF infection parameters in the Balapitiya
PHI area. Field procedures to assess LF infection parameters
were essentially the same as those previously described.9,14
Brieﬂy, ﬁeld teams for collection of demographic information
and blood samples comprised a medical ofﬁcer, a PHI, a data
entry technician, a phlebotomist, and one or two assistants.
Finger-prick blood samples were collected by sterile, single-
use, contact-activated BD-microtainer lancets (Fisher Scien-
tiﬁc, Pittsburgh, PA) into an ethylenediaminetetraacetic acid
(EDTA)-coated blood collection vial (Fisher Scientiﬁc) during
the day from consenting participants. Preprinted linear bar-
code labels (Partnered Print Solutions, Atlanta, GA) were used
to link samples to participant records. Samples were trans-
ported to the AFC laboratory in Colombo, in coolers for ﬁlarial
antigen testing. Plasma was separated from ﬁnger-prick
blood samples from school children by centrifugation and
stored at −80C for later antibody testing.
Surveillance methods in communities and in primary
schools. Comprehensive surveys for LF parameters were
performed as previously described.9 Balapitiya MOH and PHI
area maps, census information (numbers of houses, schools,
and numbers of primary grade school children) were obtained
from census records, voter lists, and from school principals
and administrators. Household sampling was achieved by
sampling an equal number of houses from all quadrants in
each of the ﬁve PHM areas within the Balapitiya PHI area with
the goal of sampling approximately 140 houses and 500
people (ages 10–70).
Primary grade school children (grades 1 and 2, ages 6–8) in
all ﬁve schools that serve theBalapitiya PHI areawere enrolled
in the study. No sampling was involved, so all children with
parental consent were tested.
Immunochromatographic card test (ICT) card tests (Binax-
NOW® Filariasis, Alere, Inc., Scarborough, ME) were used for
detecting CFA in blood samples.16 One hundred microliter of
whole blood collected in EDTA froma ﬁnger prickwas used for
antigen testing according to the manufacturer’s instructions
(Alere, Inc.). Card tests were read visually at 10minutes as per
the manufacturer’s instructions, and results were recorded
using a tablet (Google Nexus-7; ASUS Computer In-
ternational, Fremont, CA) containing the survey data entry
forms.
Immunoglobulin G4 antibodies to recombinant ﬁlarial anti-
gen Bm-14 in human plasma were detected by microplate
enzyme linked immunosorbent assay (ELISA) (Filariasis
CELISA, Cellabs Pty Ltd, Brookvale, Australia) as previously
described.9,17 Plasma samples were tested in a single well
per sample. All samples with positive or borderline test re-
sults (optical density [OD] values > 0.35) were retested on a
different day to conﬁrm positivity. Samples with two OD
values > 0.35 were considered to be positive.
Microﬁlaria testing was performed for persons with positive
ICT card testswith three-line blood smears (60 μL total volume)
preparedwith ﬁnger-prick bloodcollectedbetween9 PMand12
midnight. Blood smears were air-dried, ﬁxed, stained with
Giemsa, and examined by microscopy to detect microﬁlariae.
Anti-Filariasis Campaigns community Mf survey. The
AFC conducted a large-scale night blood Mf survey in 2016
following two rounds of MDA that were provided in 2014
and 2015. Residents aged ³ 2 years in randomly selected
households (HHs) within two public health ﬁeld ofﬁce areas
(Balapitiya and Wathugedara) within the Balapitiya MOH area
were tested. Field teams collected ﬁnger-prick blood (two
blood smears with 30 μL of blood each) at night after
20:30 hours. Slides were stained with Giemsa, and Mf was
detected by microscopy in the AFC central laboratory in
Colombo and in theRegional FilariasisUnit laboratory inGalle.
Mosquito collection for W. bancrofti DNA detection.
Culex quinquefasciatus were collected with Centers for Dis-
ease Control gravid traps (Model 1712, John W. Hock Com-
pany, Gainesville, FL) as previously described.9,15 Consent
was obtained from heads of HHs to place traps next to their
houses for 1–3 nights. In the Balapitiya PHI survey conducted
in 2015, 50 traps were placed in this PHI for collecting Culex.
To sample all areaswithin thePHI area, 10 trapswere placed in
each of the ﬁve PHM areas that comprise the PHI area. Traps
were placed outside of houses in shaded areas in four quad-
rantsof eachPHMto systematically sample all areas in thePHI
area. Four pools of 20 mosquitoes were collected from each
trap in the PHI area. A total of 200 pools were collected in 50
trap sites.
For MX surveys conducted in 2016, traps were placed in
22 PHMs (eight in the Balapitiya PHI and 14 in other areas
within the coastal Galle EU) that had high LF infection pa-
rameters in prior surveys. Traps were placed for 1–3 nights in
each quadrant of each PHM to ensure broad sampling. Two
pools of 25 mosquitoes were collected from each trap loca-
tion. Mosquitoes were sorted, dried at 95C for 1 hour, and
placed in tubes for transport to the AFC laboratory for testing.
DNAextraction and ﬁlarial DNAdetection by qPCR from
dried mosquitoes. Dried mosquitoes (limited to blood-fed,
gravid, and semi-gravid Cx. quinquefasciatus) were placed in
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Seal-Rite 2.0-mL round-bottomed microcentrifuge tubes
(USA Scientiﬁc, Inc. Ocala, FL). These were sorted into four
pools of 20 mosquitoes in each tube (2015 survey) or into
twopools of 25mosquitoes (2016survey). Approximately, 200
pools were collected from the Balapitiya PHI area in 2015 and
660 pools from the other areas in Balapitiya MOH area and
other high-risk areas in the coastal Galle EU in 2016. Isolation
of DNA from mosquitoes was performed as previously de-
scribed using Qiagen DNA extraction kits (Germantown,
MD).9,15 DNA samples were stored at −20C in sterile tubes
that were labeled with barcodes. Wuchereria bancrofti DNA
was detected in mosquito pools by qPCR as previously
described.18
Data collection, data management, and analysis. De-
mographic information from participants was collected and
entered into Motorola BLU mobile telephones (Motorola So-
lutions, Inc., Schaumburg, IL) using preloaded survey forms
produced with LINKS data collection software (https://www.
linkssystem.org). Self-reported information on the ingestion of
anti-ﬁlarial medications during national MDA program in
2000–2006, bed net usewhile sleeping the previous night, and
clinical conditions such as lymphedema and hydrocele (in
males) was collected. Participant data, their specimens, and
test results were linked to study identiﬁcation numbers us-
ing preprinted barcode labels. De-identiﬁed, cleaned data
were transferred into Microsoft Excel ﬁles (Microsoft Corp.,
Redmond, WA) for analysis.
Spatial analysis. Household locations were mapped using
ArcGIS 10.5.1 (ESRI, Redlands, CA). Symbols were color
coded to show the infection status of HH residents and HH
trap locations for mosquito pools that were collected. ArcGIS
10.5.1 was used for spatial analysis. Household and trap lo-
cationswere converted toUTMzone44NWGS84coordinates
for proximity analysis. Euclidean distances in meters from
each of the HHs to the closest positive trap were determined
using the spatial join function and then tested to ﬁnd whether
HHswith one ormore occupants with positive CFA orMf tests
were signiﬁcantly closer to positive mosquito traps than
negative HHs.
Data analysis. Fisher’s exact test and χ2 analyses were
used toassess the signiﬁcanceof differences inprevalence for
categorical ﬁlariasis parameters such as antigenemia and
antibody in human blood samples and ﬁlarial DNA in mos-
quitoes. Relationships between human and mosquito in-
fection parameters were assessed by the nonparametric
Spearman rank test. Relationships between risk factors and
antigenemia and Mf were assessed using a generalized esti-
mating equations logistic regression approach, which adjusts
estimates for correlation among subjects within a HH (SAS
9.4, SAS Institute Inc., Cary, NC). Graphs were produced with
GraphPad Prism 7 software (La Jolla, CA). Filarial DNA prev-
alence (maximum likelihood estimates with 95% CIs) was
calculated with PoolScreen 2.02 (University of Alabama at
Birmingham, Birmingham, Alabama).19,20
Ethical approval. The study protocol for comprehensive
surveillance was reviewed and approved by institutional re-
viewboardsat theUniversity ofKelaniya inSri Lankaandat the
WashingtonUniversity andby theSri LankaMinistry of Health.
Before school surveys, AFC personnel held formal meetings
with ofﬁcials from the Sri LankanMinistry of Education, school
principals, and groups of parents/guardians to discuss the
aims and procedures for the study and to provide awareness
about the signiﬁcance of the study. Anti-Filariasis Campaign
provided anti-ﬁlarial medications as per WHO guidelines to
treat infected persons who were identiﬁed during these
studies. Anti-Filariasis Campaign provided MDA to all partic-
ipants in the EU that were present during MDA campaigns
regardless of their infection status in prior surveys.
Printed copies of participant information sheets and written
consent forms were provided to participants (or to parents/
guardians) in Sinhalese, Tamil, and English. Written consent
was obtained from adults. Participation of minors required
written consent from at least one parent or guardian plus as-
sent by the child/minor.
RESULTS AND DISCUSSION
Balapitiya community survey results. The Balapitiya PHI
area (comprised ﬁve PHM areas) was surveyed for LF be-
tween March and June 2015 (Figure 1). Five hundred and
twenty-eight people from 140 HHwere enrolled in community
FIGURE 1. The map shows locations for households, primary
schools, andmosquito collection sites tested for ﬁlarial infection in the
Balapitiya Public Health Inspector (PHI) area. Blue and pink circles are
locations of houses and schools selected in this area, respectively.
Green circles indicate trap locations for collecting Culex quinque-
fasciatus. Five Public Health Midwife areas within the PHI are shown
in different colors. The geographic lines in the map represent Grama
Niladhari boundaries (Lowest administrative divisions covering
Balapitiya PHI area). The map (inset) shows the location of the
Balapitiya Medical Ofﬁcer of Health area in Galle district. This ﬁgure
appears in color at www.ajtmh.org.
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surveys (ages 10–70, mean age 36 years). Approximately,
37% of the population enrolled in the study was males; many
participants (71.5% males and 70% females) reported swal-
lowingMDAmedications at least once during the national MDA
campaign in 2002–2006. Small percentages of the surveyed
population reported that they had lymphedema or hydrocele
(0.8% and 0.5%, respectively). Sixty-ﬁve percentage of com-
munity survey participants reported that they had slept under a
bed net during the night before their enrollment in the study.
Table 1 shows combined survey results for W. bancrofti
infection parameters in the PHI. Community CFA prevalence
was 3.0%, and CFA positivity tended to be more common in
males than females (10 of 196 males or 5.1%, CI: 2.8–9.1
versus six of 332 females or 1.8%, CI: 0.8–3.9%, P = 0.06).
Microﬁlaremia also tended to be more common in males
(5/196 or 2.6%, CI: 1–6% versus one of 332 or 0.3%, CI:
0.05–1.7%, P = 0.05) (Figure 2). Community Mf prevalence
(age ³ 10) was 1.1% (CI: 0.5–2.5%), and this was higher in
adults (age ³18 years) than in school age children (aged 10–17
years who participated in the community survey) (1.4%, CI:
0.6–3.2% versus 0%, CI: 0–3.7%, P = 0.2). Most persons
with positive CFA tests and all persons with Mf were over 40
years. Six of 16CFA-positive adults hadMf (meanMf count 18
per 60 μL, range 2–58), and ﬁve of six Mf-positive participants
were adult males.
Logistic regression was used to assess several risk factors
for ﬁlarial antigenemia and Mf. Male gender was a signiﬁcant
risk factor for antigenemia (Odds ratio 2.93 [CI: 1.05–8.2], P =
0.04) and for Mf (Odds ratio 8.48 [CI: 1.003–71.7, P = 0.05]).
This male predominance is similar to that recently reported
from other areas in Sri Lanka.9,14,21 Age, bed net use, and
prior treatment of LF were not signiﬁcant risk factors for
CFAorMf. Thismaybebecause this studywasnot adequately
powered to assess the signiﬁcance of these risk factors in a
low prevalence area. Higher infection rates in adult malesmay
be due to higher baseline infection rates and/or to lower MDA
compliance in males.
These results from Balapitiya PHI illustrate a weakness in
the current WHO guidelines for post-MDA surveillance that
require pre-TAS sampling in only a few sentinel and spot
check sites within large EUs to qualify for TAS. Pre-TAS tar-
gets are 1% for Mf and 2% for CFA. If the Balapitiya PHI had
been one of the sentinel or spot check sites sampled in pre-
TAS surveys, the coastal Galle EUwould not have qualiﬁed for
TAS, and it would have required additional rounds of MDA.
School survey results. First and second grade children in
all ﬁve schools that serve the PHI were tested. Three hundred
and eighty-eight blood samples were tested for CFA, and 387
plasma sampleswere tested for antibody toBm-14 antigen by
ELISA. Five children were CFA positive (Table 1) and one of
these (a female) wasMf positive (24Mf/60μL). Three of the ﬁve
schools surveyed had at least one child with a positive CFA
test. The overall CFA prevalence in the school children was
1.2% with an upper CI value of 2.8%. Thus, a school-based
TAS limited to this part of Galle district probably would have
failed.
The anti-ﬁlarial antibody prevalence in the school survey
(5.7%, CI: 3.7–8.4%) far exceeded the prevalence and upper
conﬁdence limit targets that we have advocated in prior
publications (2%and 5%, respectively, see Table 1 and refs. 9
and 14). About half of the children surveyedweremales (53%),
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antibody rates. Only two of 22 antibody-positive childrenwere
CFA positive.
Molecular xenomonitoring results from surveys per-
formed in 2015. Four thousand mosquitoes in 200 pools (20
mosquitoes per pool) collected in the Balapitiya PHI area were
tested for W. bancrofti DNA by qPCR (Table 2). Filarial DNA
was detected inmosquitoes from 49 of 50 trap sites (Figure 2).
A very high percentage of mosquito pools (65%) contained
ﬁlarial DNA, and the upper CI for ﬁlarial DNA prevalence in
mosquitoes was much higher than the target of < 1%. These
MX results, together with high rates of antigenemia and anti-
ﬁlarial antibody in primary school children, strongly suggest
that LF transmission is ongoing in the study area.
Molecular xenomonitoring results from surveys per-
formed in 2016. Repeat MX surveys were conducted in the
Balapitiya PHI area in 2016, approximately 6 months after the
second of two rounds of supplemental MDA was provided by
the MOH and after the MX survey conducted in 2015. Three
thousand seven hundred and ﬁftymosquitoes in 150 pools (25
mosquitoesper pool) from75HH trap locationswere testedby
qPCR. Many pools were positive for ﬁlarial DNA (Table 2).
Although the ﬁlarial DNA prevalence (maximum likelihood
estimate) inmosquitoeswas signiﬁcantly lower in 2016 than in
2015, prevalence and the upper conﬁdence interval values
remained much higher than the 0.25 and 1% targets in all
PHMs tested (Table 2). The difference in the percentage of
mosquito pools positive for ﬁlarial DNA between the 2015 and
2016 surveys was not signiﬁcant. These results show that two
additional rounds of MDA were not sufﬁcient to reduce ﬁlarial
DNA rates in mosquitoes to low levels in Balapitiya.
FIGURE 2. This ﬁgure illustrates ﬁlarial antigenemia and micro-
ﬁlaremia rates by age and sex in the Balapitiya Public Health Inspector
area. These results show that although some teenagerswere infected,
most residual infections in the study area were in adult males older
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Molecular xenomonitoring results from 2016 for 22 PHM
areas in the Galle coastal EU are summarized in Figure 3.
Approximately 660poolswere collected and tested, and these
included 240 pools from the Balapitiya MOH area that were in
three different PHI areas (i.e., not limited to the Balapitiya PHI
area mentioned in the prior paragraph) (see Supplemental
Table 1). Overall, 179 of 660 (27%) pools were positive for
ﬁlarial DNA and a maximum likelihood estimate (MLE) of
1.26% (95% CI: 1.0–1.5%), and these prevalences were
above the provisional target rate (an upperCI for themaximum
likelihood rate of ﬁlarial DNA in mosquitoes of 1%). One hun-
dredandsevenof 240pools (45%, range16–63%)collected in
the Balapitiya MOH area were positive for ﬁlarial DNA. The
ﬁlarial DNA prevalence in these mosquitoes exceeded the
provisional MX target in 18 of 22 (82%) PHMs tested (Figure 3,
Supplemental Table 1). The pool screen results for MLEs,
percentage of pools positive for ﬁlarial DNA, and an average
number of trap locationspositive for ﬁlarial DNA inmosquitoes
are shown in Supplemental Table 1.
These results show that ﬁlarial DNA was still widespread in
mosquitoes in the coastal Galle EU following two supple-
mentary rounds of MDA provided in 2014 and 2015 and that
the problem was not limited to the Balapitiya PHI or to the
Balapitiya MOH area. They also suggest that mosquito
monitoring may be preferable to Mf testing in humans for
rapidly assessing the impact of interventions in areas with
low residual infection rates in post-MDA settings. That is
because MX signals for persisting LF were much stronger
than those based on CFA or Mf survey results. Finally, these
results suggest that additional rounds of routine MDA may
not be sufﬁcient to clear residual infections or interrupt
transmission of LF in coastal Galle and that other interven-
tions should be considered. These could include enhanced
MDA with improved social mobilization and directly ob-
served treatment, use of a new triple-drugMDA regimen that
has recently been endorsed by the WHO,22 and new drug
distribution activities designed to reach adult males outside
of their homes.
Additional communityMf survey results. The AFC’s night
blood survey in 2016 tested 16,927 people from the age
of 2 years in areas that included both Balapitiya and the ad-
jacent area of Wathugedara 6 months after the MDA that was
provided in 2015. Ninety-seven blood smears were positive for
W. bancrofti microﬁlariae (prevalence 0.6%, CI: 0.47–0.71%).
Microﬁlaremia prevalence was marginally higher in Balapitiya
(85 of 13,927; 0.6%, CI: 0.59–0.75%) than in Wathugedara (12
of 2,841; 0.42%, CI: 0.24–0.74%). In 2016 the overall Mf
prevalence in Galle EU by night blood smear was 0.4% (155 of
41,928). One hundred and forty-two of 155 (92%) Mf-positive
cases were reported from Balapitiya MOH area.
We previously reported that mosquito infections were high
in many areas in the Galle coastal EU that had a surveyed Mf
rate of 0.2% in 2013.15 Our newMf data and MX results show
again that mosquito infection rates can be very high in focal
areas within EUwith overall surveyedMf rates of less than 1%
in that EU. Thus, routine Mf testing is insensitive for detecting
persistent LF in post-MDA situations with low residual in-
fection rates, and the surveys are notoriously difﬁcult to per-
form well. Night blood Mf surveys may underestimate true
prevalence rates because of technical problems with the
smears or to nonparticipation of Mf carriers in surveys. Mos-
quitoes do not require participant consent when they sample
blood. Our MX results suggest that Mf carriers who were
noncompliant with MDA in the past and not sampled in the
government’s night blood surveys serve as a persistent res-
ervoir of infection that contributes to continued LF trans-
mission in hotspots such as Balapitiya in Sri Lanka.
Spatial distribution of ﬁlarial infections in humans
andmosquitoes. Figure 4 shows locations of HHswith one or
more residents that tested positive for CFA and Mf and of
mosquito trap sites that yielded pools that were positive for
ﬁlarial DNA. Circulating ﬁlarial antigenemia and Mf were de-
tected in residents of 15 of 140 (11%) and in six of 140 (4%)
houses surveyed along the length of the PHI; ﬁlarial DNA was
detected in mosquitoes collected in 49 of 50 traps placed in
the study area.
FIGURE 3. Reassessment ofWuchereria bancrofti inCulex quinquefasciatus in 2016 by molecular xenomonitoring (MX). The ﬁgure shows ﬁlarial
DNA prevalence (MLE with 95% conﬁdence intervals [CIs]) for mosquitoes collected in 22 public health midwife areas (PHMs) in the coastal Galle
evaluation unit (EU). Public Health Midwife areas 1–8 (clear bars) are in the Balapitiya Ministry of Health area; PHM areas 9–22 (shaded bars) were
additional sentinel sites in the Galle coastal evaluation unit that had high infection parameters in prior surveys. Red solid and blue dotted horizontal
lines represent a ﬁlarial DNA prevalence (maximum likelihood estimate) of 0.25% and the 1% upper CI limit for the estimate that are provisional
targets for lymphatic ﬁlariasis elimination, respectively. This ﬁgure appears in color at www.ajtmh.org.
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The median distance from CFA-positive HHs (N = 15) to the
closest positive mosquito trap was 88.9 meters (range
28–397 m), and the median distance from CFA-negative HHs
(N = 124) to the closest positive trap was 128m (range 8–401 m).
This difference is not statistically signiﬁcant (Wilcoxon rank
sum test [P=0.4]). It is possible that thenumberof positive houses
in the studywas too small to detect a spatial relationship between
human infections and positive mosquito-trapping locations.
However, prior studies by our group and others have also failed to
document this typeofspatial relationshipevenwhen infectionrates
were higher.14,23–25 This suggests that Culex mosquitoes range
widely in Sri Lanka during the interval between blood meals and
oviposition. It is also possible that a signiﬁcant amount of
mosquito feeding occurs outside of the home environment.
Additional discussion and conclusions. This study has
provided useful information on the assessment of persistent
ﬁlarial infections and probable ongoing transmission in Bala-
pitiya PHI and in other areas in the coastal Galle district
EU following multiple rounds of MDA. Two prior studies
have shown persistence of W. bancrofti in populations
approximately 6–9 years following ﬁve rounds of MDA in
several EUs in Sri Lanka including the high-risk coastal Galle
EU. This persistence is incongruous with the fact that all for-
merly endemic EUs in the country including coastal Galle EU
easily passed TAS in 2013. Those TAS results (together with
other information) led WHO to validate that Sri Lanka had
eliminated LF as a public health problem in 2016.
A post-MDA surveillance study in American Samoa (where
LF is transmitted by Aedes polynesiensis) found residual in-
fections with ongoing transmission in some hotspots26 after
the EU had passed TAS. Our results conﬁrm that passing
school-based TAS at the EU level does not prove that LF has
been eliminated from the entire EU. This study has provided
solid ﬁeld data to supportmodel-based predictions in a recent
publication that addressed heterogeneities in individual in-
fection distributions in communities that have completed
MDA and exposure heterogeneities that can lead to LF hot-
spots in areas that pass TAS in large EUs.12,27 Additional re-
search is needed to improve post-MDA surveillance methods
and to develop and test methods for hotspot removal. The Sri
Lanka AFC has started to perform additional surveillance in
humans and in mosquitoes to search for additional foci with
persistent LF in the Galle coastal EU.
Results from this study demonstrate the value of compre-
hensive surveys including MX for evaluating potential hot-
spots in EUs that have passed school-based TAS. The
BalapitiyaPHImeets our provisional deﬁnition for a LF hotspot
because it is an area smaller than anEU that hasMfprevalence
with a 95%CI of ³ 1% in adults despite ﬁve or more rounds of
effective MDA.
Antigen prevalence data from this study and in other recent
publications show that adult males account for most persis-
tent ﬁlarial infections in Sri Lanka at this time,9,14 and this is
also true in other regions that have receivedmultiple rounds of
MDA (authors’unpublisheddata). Therefore,wider application
of MX and shifting the focus of surveillance from children
(which detects more recent infections) to adults (to assess the
persisting reservoir of infection) might improve post-MDA
surveillance and hotspot detection. In a similar way, new tools
including an improved treatment regimen and targeted MDA
to increase compliance among high-risk groups may some-
times be required to remove hotspots and traverse the difﬁ-
cult the last mile to LF elimination.
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